0001437749-22-014772.txt : 20220610 0001437749-22-014772.hdr.sgml : 20220610 20220610153708 ACCESSION NUMBER: 0001437749-22-014772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220608 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Fred E CENTRAL INDEX KEY: 0001339358 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 221008723 MAIL ADDRESS: STREET 1: 301 COMMERCE STREET STREET 2: SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FC 06102022 X0306 4 2022-06-08 0001668243 UroGen Pharma Ltd. URGN 0001339358 Cohen Fred E 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Stock Option (right to buy) 7.06 2022-06-08 4 A 0 10000 0 A 2032-06-08 Ordinary Shares 10000 10000 D The shares underlying the stock option will vest in equal quarterly installments over a period of one year. /s/ Jason Smith, Attorney-in-Fact 2022-06-10